The transaction involved the sale of 3,486 shares at $1,216.21 per share, totaling ~$4.2 million on July 15, 2026.
This disposition reduced the executive's direct equity holdings by 46%.
The activity was structured as a cashless exercise, in which the insider converted 3,486 options at $284.97 and immediately liquidated the resulting shares.
The sale occurred as the company's shares realized a one-year total return of -22% through the transaction date, while the executive maintains a remaining position of 4,014 direct shares and 19,700 derivative securities.
Joel Reiss, Co-Chief Operating Officer of TransDigm Group Incorporated (NYSE:TDG), sold 3,486 shares of common stock on July 15, 2026, for approximately $4.2 million SEC Form 4 filing.
| Metric | Value |
|---|---|
| Shares sold (directly held) | 3,486 |
| Transaction value | $4.2 million |
| Post-transaction shares (directly held) | 4,014 |
| Post-transaction value | $4.95 million |
Transaction value based on SEC Form 4 weighted average sale price ($1216.21); post-transaction value based on July 15, 2026, market close ($1232.18).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-07-16) | $1,231.11 |
| Market Capitalization | $67.9 billion |
| Revenue (TTM) | $9.5 billion |
| Net Income (TTM) | $2.0 billion |
TransDigm Group is a global aerospace enterprise with $9.5 billion in TTM revenue and a market capitalization of $67.9 billion, employing 16,500 personnel across international operations. The company maintains a competitive advantage through its specialized focus on high-value, mission-critical aerospace components that demonstrate strong aftermarket demand and customer switching costs. TransDigm's diversified portfolio across power systems, airframe components, and non-aerospace applications provides revenue stability and growth opportunities across commercial aviation, defense, and industrial sectors.
Investors shouldn’t worry over Reiss’s sales as they were pre-planned transactions, rather than a vote on the stock one way or another. Furthermore, Reiss still has over 19,700 remaining derivative securities (stock options), so there is no doubt they still have plenty of “skin in the game” to align their interests with shareholders.
From a Foolish perspective on TransDigm stock, there is a lot to like about the company, especially while its shares trade near 52-week lows. While not blatantly “cheap” at 37 times earnings, this valuation is near its lowest in the last five years and isn’t outrageous for a company with TransDigm’s long history of success. TDG just grew sales by 18% in its latest quarter (11% organic) and expects revenue to grow by 18% for the full year.
While the serial acquirer appears to be doing just fine operationally, it just gave up on acquiring Stellant Systems from a private equity firm for $960 million due to regulatory uncertainty. Developments like these are worth investors’ noticing, because if TransDigm increasingly struggles to get M&A deals across the finish line, its main growth engine may start sputtering. That said, I think it’s far too early to panic and think shares are reasonably priced for access to a high-quality compounder that benefits from selling mission-critical aerospace parts.
Josh Kohn-Lindquist has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends TransDigm Group. The Motley Fool has a disclosure policy.